Accueil / Tag Archives: Contract/Agreement

Tag Archives: Contract/Agreement

Insulet prendra en charge la distribution et l’assistance commerciale de son système Omnipod® en Europe

Friday, July 21st 2017 at 2:27am UTC La distribution directe contribue à la solidité et à la croissance de la clientèle européenne et renforce les perspectives financières de la société BILLERICA, Massachusetts–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet ou la Société), le chef de file de la technologie de pompe …

Plus »

Hocoma and Saebo Partner to Deliver Compact, Affordable Rehabilitation Solution for Upper Extremities

Monday, July 17th 2017 at 2:00pm UTC ZURICH & CHARLOTTE, N.C.–(BUSINESS WIRE)– Hocoma and Saebo today announced a partnership to improve the training possibilities for patients with moderate to mild impairments of the upper extremities. Together, the SaeboMas Mini and the ArmeoSenso deliver an easy-to-use, compact solution at an affordable …

Plus »

Immune Pharmaceuticals Provides Update on Plan to Implement a Spin-off of Cytovia into a Separate Publicly Traded Oncology Company

Wednesday, July 19th 2017 at 1:32pm UTC Immune shareholders to receive additional pro rata shares in Cytovia NEW YORK–(BUSINESS WIRE)– Immune Pharmaceuticals (NASDAQ: IMNP) (“Immune”) today confirmed it is continuing to structure and pursue a spin-off of Cytovia, Inc. (“Cytovia”), its subsidiary dedicated to the development and commercialization of Oncology …

Plus »

LSGPA Invests an Additional $500,000 in MacuLogix, Inc.

Tuesday, July 18th 2017 at 8:54pm UTC Developer of FDA-Cleared AdaptDx® to Aid Diagnosis and Monitoring of Age-Related Macular Degeneration (AMD) HARRISBURG, Pa.–(BUSINESS WIRE)– The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) announced today an additional investment of $500,000 in MacuLogix, Inc. The investment was part of a syndicate with …

Plus »

OncLive® and Targeted Oncology™ Partner with the Association of Community Cancer Centers

Tuesday, July 18th 2017 at 1:34pm UTC OncLive® continues to expand Strategic Alliance Partnership program CRANBURY, N.J.–(BUSINESS WIRE)– OncLive® and Targeted Oncology™ are proud to announce they’ve partnered with the Association of Community Cancer Centers (ACCC) as a part of its Strategic Alliance Partnership (SAP) program, announced Michael J. Hennessy …

Plus »

Prana Commences Research Collaboration with Takeda for the Treatment of Parkinson’s Disease Gastrointestinal Neuropathology

Tuesday, July 18th 2017 at 1:00pm UTC PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture MELBOURNE, Australia & SAN FRANCISCO–(BUSINESS WIRE)– Prana Biotechnology Ltd (ASX:PBT)(NASDAQ:PRAN) today announced a research collaboration with Takeda Pharmaceuticals International, Inc. to study the ability of Prana’s investigational …

Plus »

New partnership between Christiana Care’s Gene Editing Institute and NovellusDx speeds progress toward personalized cancer medicine

Thursday, July 20th 2017 at 1:02pm UTC WILMINGTON, Del.–(BUSINESS WIRE)– Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx. The Gene …

Plus »

ABL Awarded NIH Contract for HIV Vaccine Development Worth up to $318 Million

Wednesday, July 19th 2017 at 2:05pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– ABL, Inc. (ABL), a global contract research and manufacturing service provider, announced today it has been awarded the recompetition of the contract for “Preclinical Development Support” (Contract # HHSN272201700010I) by the Division of AIDS (DAIDS) within the National Institute of …

Plus »

Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

Tuesday, July 18th 2017 at 6:12am UTC Telix to develop products for imaging and treatment of prostate cancer CAMBRIDGE, England & MELBOURNE, Australia–(BUSINESS WIRE)– Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licence …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...